Sarcopenia in chronic kidney disease: what have we learned so far?

Abstract:

:The term sarcopenia was first introduced in 1988 by Irwin Rosenberg to define a condition of muscle loss that occurs in the elderly. Since then, a broader definition comprising not only loss of muscle mass, but also loss of muscle strength and low physical performance due to ageing or other conditions, was developed and published in consensus papers from geriatric societies. Sarcopenia was proposed to be diagnosed based on operational criteria using two components of muscle abnormalities, low muscle mass and low muscle function. This brought awareness of an important nutritional derangement with adverse outcomes for the overall health. In parallel, many studies in patients with chronic kidney disease (CKD) have shown that sarcopenia is a prevalent condition, mainly among patients with end stage kidney disease (ESKD) on hemodialysis (HD). In CKD, sarcopenia is not necessarily age-related as it occurs as a result of the accelerated protein catabolism from the disease and from the dialysis procedure per se combined with low energy and protein intakes. Observational studies showed that sarcopenia and especially low muscle strength is associated with worse clinical outcomes, including worse quality of life (QoL) and higher hospitalization and mortality rates. This review aims to discuss the differences in conceptual definition of sarcopenia in the elderly and in CKD, as well as to describe etiology of sarcopenia, prevalence, outcome, and interventions that attempted to reverse the loss of muscle mass, strength and mobility in CKD and ESKD patients.

journal_name

J Nephrol

journal_title

Journal of nephrology

authors

Sabatino A,Cuppari L,Stenvinkel P,Lindholm B,Avesani CM

doi

10.1007/s40620-020-00840-y

subject

Has Abstract

pub_date

2020-09-02 00:00:00

eissn

1121-8428

issn

1724-6059

pii

10.1007/s40620-020-00840-y

pub_type

杂志文章,评审
  • Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease.

    abstract::Ferumoxytol is a new product approved for intravenous use by the US Food and Drug Administration (FDA) in the treatment of iron deficiency anemia in adults with chronic kidney disease. This approval was based on data from 3 open-label, randomized, controlled clinical trials. In all of these trials, ferumoxytol was wel...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/jn.5000025

    authors: Kowalczyk M,Banach M,Rysz J

    更新日期:2011-11-01 00:00:00

  • Microalbuminuria in essential hypertension.

    abstract::Some patients with essential hypertension manifest increased urinary albumin excretion (UAE). Hypertensive patients with microalbuminuria manifest abnormal circadian variation of blood pressure, increased serum levels of LDL-cholesterol and lipoprotein(a), a greater rise of serum insulin in response to an oral glucose...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Bianchi S,Bigazzi R,Campese VM

    更新日期:1997-07-01 00:00:00

  • Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.

    abstract:BACKGROUND:Causes of hypertension and cardiac hypertrophy in hemodialysis (HD) patients are multiple, but the role of fluid overload appears to be crucial. Short daily HD (sDHD = 2 hr x 6/week) seems to allow reductions in left ventricular mass (LVM) through the reduction of extracellular water (ECW). Better cardiovasc...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Fagugli RM,Pasini P,Pasticci F,Ciao G,Cicconi B,Buoncristiani U

    更新日期:2006-01-01 00:00:00

  • Nrf2 and Sp family synergistically enhance the expression of ion transporters in potassium-depleted conditions.

    abstract:INTRODUCTION:During potassium (K) depletion, many adaptive responses are likely mediated through a complex network that involves expression of a variety of genes. We identified that the Nrf2 gene was differentially expressed between normal and K-depleted rat kidney. METHODS:To investigate the effect of Nrf2 on colonic...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/JN.2011.8448

    authors: Lee CB,Lee YS,Lee JY,Lee SE,Ahn KY

    更新日期:2012-03-01 00:00:00

  • Renal cortical thickness and PON1 activity both decrease in chronic renal failure.

    abstract:BACKGROUND:Chronic renal failure (CRF) is associated with a tendency to atherosclerosis due to the enhanced oxidative stress and insufficient antioxidant enzyme activities such as superoxide dismutase (SOD), catalase (CAT) and paraoxonase (PON 1), together with abnormalities in lipid parameters. We determined the in vi...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Ak G,Ozgönül M,Sözmen EY,Aslan SL,Sözmen B

    更新日期:2002-03-01 00:00:00

  • Gene transfer and kidney disease.

    abstract::There is little doubt that molecular biological intervention therapy has come of age and its potential is arousing tremendous excitement. A gene transfer technique, the HVJ-liposome method, is now applicable as a tool for the dissection of molecular aspects in the pathophysiology of renal diseases, and for gene therap...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Imai E,Isaka Y,Akagi Y,Kaneda Y,Hori M

    更新日期:1998-01-01 00:00:00

  • Urinary IgM excretion: a reliable marker for adverse pregnancy outcomes in women with chronic kidney disease.

    abstract:OBJECTIVE:Chronic kidney disease (CKD) pregnancies are at high risk of developing adverse outcomes. In non-pregnant subjects with CKD, higher urinary IgM levels are associated with poor renal survival and higher rates of cardiovascular deaths. In this study, we assessed whether urinary IgM levels are associated with an...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-018-0536-9

    authors: Leaños-Miranda A,Campos-Galicia I,Ramírez-Valenzuela KL,Berumen-Lechuga MG,Isordia-Salas I,Molina-Pérez CJ

    更新日期:2019-04-01 00:00:00

  • Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease.

    abstract:BACKGROUND AND AIMS:This study aimed to test the hypothesis that visfatin is associated with atherosclerosis in patients with chronic kidney disease (CKD). METHODS:In the study, we measured serum triglycerides, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol lev...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/jn.2010.3488

    authors: Mu J,Feng B,Ye Z,Yuan F,Zeng W,Luo Z,Qi W

    更新日期:2011-03-01 00:00:00

  • Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results.

    abstract:BACKGROUND:The success of guidelines depends largely on effective implementation and uptake in clinical practice. The Optimal Renal Anemia Management Assessment (ORAMA) study investigated the impact of European Best Practice Guideline (EBPG) prompting on patient outcomes. METHODS:ORAMA was a prospective, international...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:

    authors: Locatelli F,Covic A,Macdougall IC,Scherhag A,Wiecek A,ORAMA Study Group.

    更新日期:2009-09-01 00:00:00

  • Lymphocyte costimulatory receptors in renal disease and transplantation.

    abstract::Cell-to-cell signal exchange during antigen presentation deeply influences the profile and extent of the immune response. Together with the TCR/MHC-mediated signal, accessory signals are provided to the T cell by the antigen-presenting cell (APC), through specific receptor-ligand interactions that represent indispensa...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Biancone L,Deambrosis I,Camussi G

    更新日期:2002-01-01 00:00:00

  • Recent insights into vitamin D and its receptor.

    abstract::The widely differing functions of vitamin D are based both on a wide diffusion of its specific receptor (VDR) and on the ability of many cells, in addition to renal tubular cells, to synthesize calcitriol for autocrine and paracrine functions. In the last few years, many published studies have added new insights into ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/JN.2011.7767

    authors: Messa P,Alfieri C,Rastaldi MP

    更新日期:2011-05-01 00:00:00

  • Kidney transplantation and enzyme replacement therapy in patients with Fabry disease.

    abstract::During Fabry disease, progressive glycosphingolipid deposition in the kidney causes gradual deterioration of renal function with proteinuria, uremia and hypertension. This results in end-stage renal disease (ESRD) which is one of the leading causes of morbidity and premature mortality in affected patients. Given the e...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/jn.5000214

    authors: Cybulla M,Kurschat C,West M,Nicholls K,Torras J,Sunder-Plassmann G,Feriozzi S

    更新日期:2013-07-01 00:00:00

  • Wild-type uromodulin prevents NFkB activation in kidney cells, while mutant uromodulin, causing FJHU nephropathy, does not.

    abstract:BACKGROUND:Uromodulin (Tamm-Horsfall protein) is the most abundant urinary protein in healthy individuals. Despite 60 years of research, its physiological role remains rather elusive. Familial juvenile hyperuricemic nephropathy and medullary cystic kidney disease Type 2 are autosomal dominant tubulointerstitial nephrop...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-014-0079-7

    authors: Dinour D,Ganon L,Nomy LI,Ron R,Holtzman EJ

    更新日期:2014-06-01 00:00:00

  • Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study.

    abstract::Highly concentrated marine polyunsaturated fatty acids (n-3 PUFA), affecting the lipids and lipophilic drugs metabolism, can interfere with cyclosporine (CyA) pharmacokinetics. This prospective, randomized and placebo-controlled, double-blind study involved 42 kidney graft recipients. From day +1, 21 pts (E) received ...

    journal_title:Journal of nephrology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Busnach G,Stragliotto E,Minetti E,Perego A,Brando B,Broggi ML,Civati G

    更新日期:1998-03-01 00:00:00

  • Proteinase 3/myeloblastin as a growth factor in human kidney cells.

    abstract:BACKGROUND:Numerous data support the possible role of myeloblastin/proteinase 3 (PR3) in growth and differentiation of neutrophil granulocytes and certain monocyte subtypes. However, whether PR3 is expressed in non-myeloid cells remains a matter of debate even though recent studies clearly demonstrated its expression i...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Relle M,Mayet WJ,Strand D,Brenner W,Galle PR,Schwarting A

    更新日期:2003-11-01 00:00:00

  • Primary renal lymphoma and xanthogranulomatous pyelonephritis in childhood.

    abstract::Primary renal non-Hodgkin's lymphoma is very rare in childhood. A six-year-old boy presented with bilateral non-obstructive multinodular nephromegaly and renal failure. Percutaneous needle biopsy showed large-cell lymphoma. The patient was started on chemotherapy. A right nephrectomy was done when systemic hypertensio...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Karadeniz C,Oguz A,Ataoglu O,Citak C,Buyan N,Pinarli G,Ozkaya O,Kapucu O

    更新日期:2002-09-01 00:00:00

  • Acute colchicine intoxication during clarithromycin administration in patients with chronic renal failure.

    abstract::Colchicine is an effective antiinflammatory medication. It should be used with great caution, however, in patients requiring dialysis. Coadministration of colchicine and macrolides may impair colchicine elimination, resulting in excess drug exposure and toxicity. We report 2 renal failure cases of colchicine intoxicat...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Akdag I,Ersoy A,Kahvecioglu S,Gullulu M,Dilek K

    更新日期:2006-07-01 00:00:00

  • Dialysis requirement, long-term major adverse cardiovascular events (MACE) and all-cause mortality in hospital acquired acute kidney injury (AKI): a propensity-matched cohort study.

    abstract:BACKGROUND:Dialysis-requiring acute kidney injury (D-AKI) is common in hospitalized patients. Many patients survive the immediate post AKI period, thus at risk of suffering long-term sequelae of AKI. Prior studies examining long term outcomes lack non-dialyzed AKI control groups. Without non-dialyzed AKI control group,...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-016-0321-6

    authors: Omotoso BA,Abdel-Rahman EM,Xin W,Ma JZ,Scully KW,Arogundade FA,Balogun RA

    更新日期:2016-12-01 00:00:00

  • Determinants and survival implications of low bone mineral density in end-stage renal disease patients.

    abstract:BACKGROUND:Reduced bone mineral density (BMD) is common in end-stage renal disease (ESRD) patients and predicts outcomes. The chronic kidney disease-mineral bone disorder contributes to low BMD in ESRD; however, the impact of classical risk factors for osteoporosis in the general population, such as body weight and fat...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/jn.5000185

    authors: Park SH,Jia T,Qureshi AR,Bárány P,Heimbürger O,Larsson TE,Axelsson J,Stenvinkel P,Lindholm B

    更新日期:2013-05-01 00:00:00

  • Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.

    abstract:BACKGROUND:The most frequent cause of death in hemodialysis (HD) patients is cardiovascular disease (CVD), and chronic inflammation has been identified as an epidemiologically important risk factor for CVD. Elevated levels of minor acute phase reactants, such as ceruloplasmin (Cp) and transferrin, have been related to ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Panichi V,Taccola D,Rizza GM,Consani C,Migliori M,Filippi C,Paoletti S,Sidoti A,Borracelli D,Panicucci E,Giovannini L

    更新日期:2004-09-01 00:00:00

  • The danger control concept in kidney disease: mesangial cells.

    abstract::Kidney remodeling is a response to intrinsic or extrinsic triggers of kidney injury. Injury initiates a set of universal response programs that were positively selected through evolution to control potentially life-threatening dangers and to regain homeostasis, including tissue repair. These danger control programs ar...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/jn.5000247

    authors: Migliorini A,Ebid R,Scherbaum CR,Anders HJ

    更新日期:2013-05-01 00:00:00

  • Fibroblast growth factor 23: are we ready to use it in clinical practice?

    abstract::Patients with chronic kidney disease (CKD) have a greatly enhanced risk of cardiovascular morbidity and mortality. Over the past decade it has come clear that a disturbed calcium-phosphate metabolism, with Fibroblast Growth Factor-23 as a key hormone, is partly accountable for this enhanced risk. Numerous studies have...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-020-00715-2

    authors: Bouma-de Krijger A,Vervloet MG

    更新日期:2020-06-01 00:00:00

  • Effect of gender on various parameters of crush syndrome victims of the Marmara earthquake.

    abstract:BACKGROUND:Detailed analyses on crush syndrome resulting from earthquakes is scarce. This study aimed to analyze the effect of gender on clinical course of the renal victims of the catastrophic Marmara earthquake that struck Northwestern Turkey in 1999. METHODS:Questionnaires were prepared within the first week of dis...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Sever MS,Erek E,Vanholder R,Lameire N

    更新日期:2004-05-01 00:00:00

  • Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.

    abstract::It has been increasingly apparent that end-stage renal disease (ESRD) patients carry an inflammatory burden, which may play a pivotal role in the evolution of not only wasting but also of the massive increase in the relative risk of cardiovascular disease (CVD). Also increased oxidative stress (an impairment of the pr...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Maruyama Y,Lindholm B,Stenvinkel P

    更新日期:2004-11-01 00:00:00

  • Treatment of reduced bone density with ibandronate in dialysis patients.

    abstract::Bisphosphonates inhibit bone resorption and are widely used to treat osteolytic metastases and osteoporosis. Renal osteodystrophy patients have continuous bone loss due to chronically elevated parathyroid hormone (PTH). In this open-label study, ibandronate was evaluated for the treatment of reduced bone density in re...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,随机对照试验

    doi:

    authors: Bergner R,Henrich D,Hoffmann M,Schmidt-Gayk H,Lenz T,Upperkamp M

    更新日期:2008-07-01 00:00:00

  • Improvement of hypertension and LVH in maintenance hemodialysis patients treated with sustained-release isosorbide mononitrate.

    abstract:BACKGROUND:Hypertension and left ventricular hypertrophy (LVH) are independent predictors of morbidity and mortality in maintenance hemodialysis (MHD) patients. The level of serum asymmetric dimethylarginine (ADMA) is increased in MHD patients, which is a kind of uremic toxin. It can competitively inhibit nitric oxide ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,随机对照试验

    doi:10.5301/jn.2011.6252

    authors: Li H,Wang SX

    更新日期:2011-03-01 00:00:00

  • Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study.

    abstract:BACKGROUND:Drug-related problems (DRPs) are common in chronic kidney disease (CKD) patients. We developed a 2-step consultation including a clinical pharmacist (CP) session and a nephrologist conventional care consultation to explore the feasibility of a pilot drug-oriented disease management program in controlling iat...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/jn.5000063

    authors: Belaiche S,Romanet T,Allenet B,Calop J,Zaoui P

    更新日期:2012-09-01 00:00:00

  • Chronic hypotension in the dialysis patient.

    abstract::Chronic hypotension, defined by a systolic blood pressure < 100 mmHg in the interdialytic period, affects 5-10% of hemodialysis patients, and is more prevalent among patients on long-term hemodialysis. This complication requires a substantial amount of medical and nursing care before and during dialysis to control its...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Cases A,Coll E

    更新日期:2002-07-01 00:00:00

  • A comparison of methods for the measurement of hemodialysis access recirculation.

    abstract:BACKGROUND:NKF K-DOQI clinical practice guidelines recommend a regular monitoring of vascular access (VA) through several methods, such as VA recirculation (AR). Assessment of AR is crucial to avoid inefficiency of hemodialysis (HD). A non-urea based method has been developed (ultrasound dilution Transonics Hemodialysi...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Basile C,Ruggieri G,Vernaglione L,Montanaro A,Giordano R

    更新日期:2003-11-01 00:00:00

  • Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent?

    abstract::Sclerosing encapsulating peritonitis (SEP) is a serious complication of long-term continuous ambulatory peritoneal dialysis (CAPD), very likely related to a persisting expression of the transforming growth factor beta1 (TGFbeta1) gene on peritoneal mesothelial cells. We report the case of a 67-year-old uremic woman wh...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Allaria PM,Giangrande A,Gandini E,Pisoni IB

    更新日期:1999-11-01 00:00:00